Skip to main content

Short Reads/Fingerprints: May 1, 2003


Former Aclara Biosciences CEO Joseph Limber has been appointed interim CEO of Deltagen. When Deltagen closes a private placement round worth at least $10 million, Limber will take over permanently.

The UK Biobank has named Oxford University epidemiologist John Newton its CEO. Newton is also director of R&D at the Oxford Radcliffe Hospitals NHS Trust.

Robert Friedman will serve as vice president for environment and energy policy at Craig Venter’s Center for the Advancement of Genomics and the Institute for Biological Energy Alternatives. Friedman leaves the Heinz Center, where he was a VP.

Larry Felser is the new director of systems and software development for Gene Network Sciences of Ithaca, NY. Felser comes from Autodesk, where he was a director for software development.

Keith Dunker becomes director of the Center for Bioinformatics at Indiana University’s School of Medicine, part of the Indiana Genomics Initiative.

MichBio, a biosciences industry association in Michigan, has appointed Michael Witt as executive director. Witt, a healthcare attorney turned biotech entrepreneur, has helped found five companies in such fields as genomics and bioinformatics.

Robert McBurney has been appointed CSO and senior vice president for R&D at Waltham, Mass-based Beyond Genomics. He hails from Differential Proteomics with fellow co-founder Paul Stroobant, who has also joined Beyond Genomics as vice president for biochemistry and chemistry.

Michael Berens, a researcher at Arizona’s Translational Genomics Research Institute, is the new CEO of the International Genomics Consortium. The Phoenix, Ariz.-based consortium also named Robert Penny as chief medical officer, Michael Bittner as chief research officer, and Michael Rodgers as chief financial officer.

From Cambridge to Cambridge: Whitehead’s genome center announced that Patrick Kleyn joins as director of scientific planning, a newly created position. Kleyn was last CSO at Gemini Genomics in Cambridge, UK.

Former Blackstone Computing CEO and president Brian Ritchie has joined storage consulting services firm GlassHouse Technologies as senior VP of sales. TurboWorx announced this spring that it would acquire Blackstone, now known as Argentys.

Vincent Forlenza becomes president of Becton, Dickinson subsidiary BD Biosciences. A 23-year veteran of Becton, Dickinson, he most recently served as senior vice president of technology, strategy, and development for the company.


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.